Skip to main content

Featured

The Loonie Just Hit an 8-Week High — Here's What a Stronger Dollar Means for You

  August 11, 2026 Three weeks ago, we told you the Canadian dollar had crashed to a 14-month low . This week, it's doing the opposite: the loonie just touched its strongest level since June, and it's not a small bounce. If you shop online, travel south, or hold US stocks in your RRSP or TFSA, this move actually moves your numbers. What actually happened The Canadian dollar strengthened to about 1.393–1.394 per US dollar — roughly 71.7 to 71.8 US cents — its best level in eight weeks, according to Reuters and TradingEconomics data. That's a meaningful move: the loonie has gained close to 2% against the greenback since hitting 1.4248 on July 25, and it's up about 1.6% over the past month alone. THE TURNAROUND, IN THREE NUMBERS July 25 (14-month low) 1.4248 USD/CAD Today (8-week high) ~1.394 USD/CAD Move since July 25 Loonie up ~2.2% Two things are driving it. First, Friday's July jobs report blew past every forecast — the Canadian economy added 75,100 jobs against ...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments